Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study.

Fisher, Anat; Kim, Jason D; Dormuth, Colin R

Fisher, Anat; Kim, Jason D; Dormuth, Colin R.

Afiliação

Fisher A; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
Kim JD; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
Dormuth CR; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia Victoria Office, Suite 210, 1110 Government Street, Victoria, BC V8W 1Y2, Canada.

Gastroenterol Res Pract ; 2023: 2794220, 2023.

Article em En | MEDLINE | ID: mdl-36911254

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Gastroenterol Res Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google